Higher plasma levels of syndecan-1 were also associated with higher all-cause mortality and rehospitalization in HF patients with preserved ejection fraction, signifying the association of glycocalyx degradation with adverse patient outcome [76]. The gene discussed is SDC1; the disease is hydrops fetalis.